Deborah Dunsire has been appointed president and CEO of H. Lundbeck AS, as of Sept. 1, 2018. Anders Götzsche, who has been acting as interim CEO and CFO since November 2017, will resume his position as CFO of the Danish neuroscience specialist. Most recently Dunsire was president and CEO of XTuit Pharmaceuticals Inc.. She was previously CEO of Forum Pharmaceuticals Inc. and Millennium Pharmaceuticals Ltd., both before and after it was acquired by Takeda Pharmaceutical Co. Ltd..
Appointments: New CEOs For Lundbeck, Voyager & Neos, CSOs For iTeos & Tilos
Deborah Dunsire’s appointment to lead Lundbeck tops this week’s list of new hires; Astellas, Orchard Therapeutics, Voyager Therapeutics, iTeos Therapeutics, Cevec Pharmaceuticals, Sangamo Therapeutics, Cedilla Therapeutics, Tilos Therepautics and Neos Therapeutics have also appointed new executives and directors.